Form ARS - Annual Report to Security Holders:
SEC Accession No. 0000950170-25-052204
Filing Date
2025-04-08
Accepted
2025-04-08 17:25:39
Documents
1
Period of Report
2024-12-31
Effectiveness Date
2025-04-08

Document Format Files

Seq Description Document Type Size
1 ARS vktx-2025-04-07-ars_v2.pdf ARS 1237156
  Complete submission text file 0000950170-25-052204.txt   1705138
Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121 858-704-4660
Viking Therapeutics, Inc. (Filer) CIK: 0001607678 (see all company filings)

EIN.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-37355 | Film No.: 25823037
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)